方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| UCLA前列腺癌指数：前列腺癌特异性生活质量功能评估× | EORTC QLQ-BR23：乳腺癌生活质量× | |
|---|---|---|
| 领域 | 肿瘤学 | 肿瘤学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1998 | 1996 |
| 提出者≠ | Litwin, M. S., et al. | Sprangers, M. A., et al. (EORTC Quality of Life Group) |
| 类型 | Self-report questionnaire | Self-report questionnaire |
| 开创性文献≠ | Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. DOI ↗ | Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗ |
| 别名≠ | UCLA PCI, PCI | QLQ-BR23 |
| 相关 | 5 | 5 |
| 摘要≠ | The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes. | The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research. |
| ScholarGate数据集 ↗ |
|
|